EBIT Margin (Annual)

EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues

CVS Health Corporation (CVS) had EBIT Margin of 2.28% for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$372.81B
Net Income	$4.61B
Cost of Goods Sold	$206.29B
Gross Profit	$166.52B
Operating Expenses	$364.29B
Operating Income	$8.52B
Non-Operating Income/Expense	$-2.37B
Pre-Tax Income	$6.15B
Normalized Pre-Tax Income	$6.15B
Income after Taxes	$4.59B
Income from Continuous Operations	$4.59B
Consolidated Net Income/Loss	$4.59B
Normalized Income after Taxes	$4.59B
EBIT	$8.52B
EBITDA	$13.11B
Weighted-Average Shares Outstanding (Basic)	1.26B
Weighted-Average Shares Outstanding (Diluted)	1.26B
Earnings per Share (EPS) (Basic)	$3.67
Earnings per Share (EPS) (Diluted)	$3.66
Balance Sheet Financials
Current Assets	$68.64B
Property, Plant, and Equipment	$12.99B
Long-Term Assets	$184.57B
Total Assets	$253.22B
Current Liabilities	$84.61B
Long-Term Debt	$60.53B
Long-Term Liabilities	$92.88B
Total Liabilities	$177.49B
Common Equity	$75.73B
Tangible Shareholders Equity	$-42.87B
Shareholders Equity	$75.73B
Common Shares Outstanding	1.26B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$9.11B
Cash Flow from Investing Activities	$-7.61B
Cash Flow from Financial Activities	$-1.14B
Beginning Cash	$8.53B
End Cash	$8.88B
Increase/Decrease in Cash	$359.00M
Stock-Based Compensation	$540.00M
Common Stock Dividends Paid	$-3.37B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.81
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	0.88
Gross Margin	44.67%
Operating Margin	2.28%
EBIT Margin	2.28%
EBITDA Margin	3.52%
Pre-Tax Profit Margin	1.65%
Profit Margin	1.24%
Free Cash Flow	$6.33B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.47
Inventory Turnover	11.39
Receiveable Turnover	10.22
Days Sales in Receivables	35.71
Return on Equity	6.06%
Return on Tangible Equity	-10.70%
Return on Assets	1.81%
Return on Investments	3.37%
Book Value Per Share	$60.10
Free Cash Flow per Share	$5.01
Operating Cash Flow per Share	$7.22

Data from Zacks Investment Research, Inc.